{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "65862-074",
      "generic_name": "Citalopram Hydrobromide",
      "labeler_name": "Aurobindo Pharma Limited",
      "brand_name": "Citalopram Hydrobromide",
      "active_ingredients": [
        {
          "name": "CITALOPRAM HYDROBROMIDE",
          "strength": "10 mg/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "65862-074-24",
          "description": "240 mL in 1 BOTTLE (65862-074-24)",
          "marketing_start_date": "20060828",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Aurobindo Pharma Limited"
        ],
        "rxcui": [
          "309313"
        ],
        "spl_set_id": [
          "e7a2cbdd-1bdb-4e59-a3dd-298a189753ae"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "I1E9D14F36"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "SOLUTION",
      "spl_id": "7cecadcf-9da0-41e4-b9fd-0fe04572dcd8",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20060828",
      "product_id": "65862-074_7cecadcf-9da0-41e4-b9fd-0fe04572dcd8",
      "application_number": "ANDA077812",
      "brand_name_base": "Citalopram Hydrobromide",
      "pharm_class": [
        "Serotonin Reuptake Inhibitor [EPC]",
        "Serotonin Uptake Inhibitors [MoA]"
      ]
    }
  ]
}